- Treatment of non-small cell lung cancer with a driver mutation2022 | Faculty of Medicine in Pilsen
- Strategy of treatment in metastatic non-small cell lung cancer with driver mutations2016 | Faculty of Medicine in Pilsen
- First-line treatment for non-squamous NSCLC without driver mutations2022 | Third Faculty of Medicine
- The evolving landscape of biomarker testing for non-small cell lung cancer in Europe2021 | Faculty of Medicine in Hradec Králové
- Predictive testing in non-small cell lung carcinoma2021 | First Faculty of Medicine, Third Faculty of Medicine
- A comprehensive evaluation of pathogenic mutations in primary cutaneous melanomas, including the identification of novel loss-of-function variants2019 | First Faculty of Medicine
- Chronic Inflammation Promotes Cancer Progression as a Second hit2023 | Second Faculty of Medicine, Faculty of Science
- How many lines of treatment can be given to a patient with non-small cell lung cancer – case report2023 | Third Faculty of Medicine
- Amivantamab in non‐small cell lung cancer treatment2023 | Third Faculty of Medicine
- Strategy of treatment of metastatic non-small-cell lung cancer - squamous cell carcinoma2016 | First Faculty of Medicine
- A targeted diagnostic procedure and a treatment of an advanced lung carcinoma -the case report of a successful cooperation of four clinic departments, and crizotinib in a treatment of ROS 1 positive NSCLC2018 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- Current treatment options for squamous cell carcinoma of the lung2018 | Faculty of Medicine in Pilsen
- Rare case of choroidal metastasis in ALK-positive NSCLC that responds to crizotinib2019 | First Faculty of Medicine
- Perspectives in the treatment of less common mutations in patients with non-small cell lung carcinoma2023 | Publication without faculty affiliation
- Update on the 2016 WHO classification of tumors of the central nervous systém Part 1: Diffusely infiltrating gliomas2017 | Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Biomarkers in the management of lung cancer: changing the practice of thoracic oncology2023 | Faculty of Medicine in Hradec Králové
- RAF1 gene fusions as a possible driver mechanism in rare BAP1 - inactivated melanocytic tumors: a report of 2 cases2020 | Faculty of Medicine in Pilsen
- Spliceosomal gene aberrations are rare, coexist with oncogenic mutations, and are unlikely to exert a driver effect in childhood MDS and JMML2012 | Second Faculty of Medicine
- Overexpression of MYB drives proliferation of CYLD-defective cylindroma cells2016 | Faculty of Medicine in Pilsen
- Many Distinct Ways Lead to Drug Resistance in BRAF- and NRAS-Mutated Melanomas2021 | First Faculty of Medicine
- Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenome2022 | Second Faculty of Medicine
- BAP1-Inactivated Melanoma Arising From BAP1-Inactivated Melanocytic Tumor in a Patient With BAP1 Germline Mutation: A Case Report and Review of the Literature2023 | Faculty of Medicine in Pilsen
- Ntrk fusion genes in thyroid carcinomas: Clinicopathological characteristics and their impacts on prognosis2021 | Second Faculty of Medicine, First Faculty of Medicine, Central Library of Charles University, Third Faculty of Medicine
- Mutations in the RAS/MAPK Pathway Drive Replication Repair-Deficient Hypermutated Tumors and Confer Sensitivity to MEK Inhibition2021 | Second Faculty of Medicine
- Ameloblastic fibrosarcoma: clinicopathological and molecular analysis of seven cases highlighting frequent BRAF and occasional NRAS mutations2020 | Faculty of Medicine in Pilsen
- Current procedures and news in the treatment of lung cancer2021 | First Faculty of Medicine
- RET fusion genes in pediatric and adult thyroid carcinomas: cohort characteristics and prognosis2023 | Second Faculty of Medicine, First Faculty of Medicine, Third Faculty of Medicine
- PD-L1 expression and association with genetic background in pheochromocytoma and paraganglioma2022 | First Faculty of Medicine, Faculty of Science
- Novel insights into the BAP1-inactivated melanocytic tumor2022 | Faculty of Medicine in Pilsen
- Aging-Related Gene Expression Signatures Define Likelihood of Disease Progression in Patients with Lower-Risk Myelodysplastic SyndromesPublication without faculty affiliation